Angiotensin1-7 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress by preventing ROS-associated mitochondrial dysfunction and activating the Akt signaling pathway

Acta Histochemica

Volumn 117, Issue 8, 2015, Pages 803-810

  Zhao, Pengjun ^a   Li, Fen ^a   Gao, Wei ^a   Wang, Jing ^a   Fu, Lijun ^a   Chen, Yiwei ^a   Huang, Meirong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Akt signaling pathway; Angiotensin1 7; Apoptosis; Hypoxia reoxygenation; Mitochondrial dysfunction

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOTENSIN; ANGIOTENSIN 1-7; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ANGIOTENSIN I; ANGIOTENSIN I (1-7); CARDIOTONIC AGENT; OXYGEN; PEPTIDE FRAGMENT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HEART DISEASE; HYPOXIA; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; RAT; REOXYGENATION; SIGNAL TRANSDUCTION; ANIMAL; CELL HYPOXIA; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; HEART MITOCHONDRION; METABOLISM; PHYSIOLOGY; PRECLINICAL STUDY;

ANGIOTENSIN I; ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; CELL HYPOXIA; CELL LINE; CELL SURVIVAL; DRUG EVALUATION, PRECLINICAL; MITOCHONDRIA, HEART; MYOCYTES, CARDIAC; OXIDATIVE STRESS; OXYGEN; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84957729510     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2015.07.004     Document Type: Article

References (37)

1. Becker, L.B., New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61 (2004), 461–470.
2. Bell, J.R., Vila-Petroff, M., Delbridge, L.M., CaMKII-dependent responses to ischemia and reperfusion challenges in the heart. Front. Pharmacol., 5, 2014, 96.
3. Bolli, R., Jeroudi, M.O., Patel, B.S., DuBose, C.M., Lai, E.K., Roberts, R., et al. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc. Natl. Acad. Sci. U.S.A. 86 (1989), 4695–4699.
4. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976), 248–254.
5. Chang, G., Zhang, D., Liu, J., Zhang, P., Ye, L., Lu, K., et al. Exenatide protects against hypoxia/reoxygenation-induced apoptosis by improving mitochondrial function in H9c2 cells. Exp. Biol. Med. 239 (2014), 414–422.
6. Fan, T.J., Han, L.H., Cong, R.S., Liang, J., Caspase family proteases and apoptosis. Acta Biochim. Biophys. Sin. 37 (2005), 719–727.
7. Giani, J.F., Gironacci, M.M., Munoz, M.C., Pena, C., Turyn, D., Dominici, F.P., Angiotensin-(1-7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. Am. J. Physiol. Heart Circ. Physiol. 293 (2007), H1154–H1163.
8. Giordano, F.J., Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest. 115 (2005), 500–508.
9. Gottlieb, R.A., Mitochondria: execution central. FEBS Lett. 482 (2000), 6–12.
10. Grobe, J.L., Der Sarkissian, S., Stewart, J.M., Meszaros, J.G., Raizada, M.K., Katovich, M.J., ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts. Clin. Sci. 113 (2007), 357–364.
11. Jiang, F., Yang, J., Zhang, Y., Dong, M., Wang, S., Zhang, Q., et al. Angiotensin-converting enzyme 2 and angiotensin1-7: novel therapeutic targets. Nat. Rev. Cardiol. 11 (2014), 413–426.
12. Jiang, T., Gao, L., Shi, J., Lu, J., Wang, Y., Zhang, Y., Angiotensin-(1-7) modulates renin-angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats. Pharmacol. Res. 67 (2013), 84–93.
13. Kamga Pride, C., Mo, L., Quesnelle, K., Dagda, R.K., Murillo, D., Geary, L., et al. Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia/reperfusion. Cardiovasc. Res. 101 (2014), 57–68.
14. Kang, P.M., Haunstetter, A., Aoki, H., Usheva, A., Izumo, S., Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ. Res. 87 (2000), 118–125.
15. Li, C.J.R.M., Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. – Cell Physiol., 282, 2002 C227-C41.
16. Liao, X., Wang, L., Yang, C., He, J., Wang, X., Guo, R., et al. Cyclooxygenase mediates cardioprotection of angiotensin-(1-7) against ischemia/reperfusion-induced injury through the inhibition of oxidative stress. Mol. Med. Rep. 4 (2011), 1145–1150.
17. Mahon, J.M., Carr, R.D., Nicol, A.K., Henderson, I.W., Angiotensin(1-7) is an antagonist at the type 1 angiotensin II receptor. J. Hypertens. 12 (1994), 1377–1381.
18. Matsui, T., Nagoshi, T., Rosenzweig, A., Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival. Cell Cycle 2 (2003), 219–222.
19. Matsui, T., Tao, J., del Monte, F., Lee, K.-H., Li, L., Picard, M., et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104 (2001), 330–335.
20. Michiels, C., Physiological and pathological responses to hypoxia. Am. J. Pathol. 164 (2004), 1875–1882.
21. Moon, J.-Y., Tanimoto, M., Gohda, T., Hagiwara, S., Yamazaki, T., Ohara, I., et al. Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD (P) H oxidase activation in type 2 diabetic nephropathy of KK-Ay/Ta mice. Am. J. Physiol. – Renal Physiol. 300 (2011), F1271–F1282.
22. Mori, J., Patel, V.B., Ramprasath, T., Alrob, O.A., DesAulniers, J., Scholey, J. W, Lopaschuk, G.D., Oudit, G.Y., Angiotensin1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity. Am. J. Physiol. – Renal Physiol. 306 (2014), F812–F821.
23. Muthalif, M.M., Benter, I.F., Uddin, M.R., Harper, J.L., Malik, K.U., Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. J. Pharmacol. Exp. Ther. 284 (1998), 388–398.
24. Ott, M., Robertson, J.D., Gogvadze, V., Zhivotovsky, B., Orrenius, S., Cytochrome c release from mitochondria proceeds by a two-step process. Proc. Natl. Acad. Sci. U.S.A. 99 (2002), 1259–1263.
25. Pachori, A.S., Smith, A., McDonald, P., Zhang, L., Dzau, V.J., Melo, L.G., Heme-oxygenase-1 induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway. J. Mol. Cell. Cardiol. 43 (2007), 580–592.
26. Parvin, A.A., Shalini, U., Devendran, A., Baker, J.E., Dhanasekaran, A., Erythropoietin protects cardiomyocytes from cell death during hypoxia/reperfusion injury through activation of survival signaling pathways. PLOS ONE, 9, 2014, e107453.
27. Powers, S.K., Murlasits, Z., Wu, M., Kavazis, A.N., Ischemia-reperfusion-induced cardiac injury: a brief review. Med. Sci. Sports Exerc. 39 (2007), 1529–1536.
28. Saikumar, P., Dong, Z., Weinberg, J.M., Venkatachalam, M.A., Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 17 (1998), 3341–3349.
29. Sampaio, W.O., Souza dos Santos, R.A., Faria-Silva, R., da Mata Machado, L.T., Schiffrin, E.L., Touyz, R.M., Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49 (2007), 185–192.
30. Santos, R.A.S., Campagnole-Santos, M.J., Andrade, S.P., Angiotensin-(1-7): an update. Regul. Pept. 91 (2000), 45–62.
31. Scarabelli, T.M., Stephanou, A., Pasini, E., Comini, L., Raddino, R., Knight, R.A., et al. Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circul. Res. 90 (2002), 745–748.
32. Scorrano, L., Ashiya, M., Buttle, K., Weiler, S., Oakes, S.A., Mannella, C.A., et al. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev. Cell 2 (2002), 55–67.
33. Sun, J., Sun, G., Meng, X., Wang, H., Wang, M., Qin, M., et al. Ginsenoside RK3 prevents hypoxia-reoxygenation induced apoptosis in H9c2 cardiomyocytes via AKT and MAPK pathway. Evid. Based Complement. Altern. Med., 2013, 2013, 690190.
34. van Meerloo, J., Kaspers, G.J., Cloos, J., Cell sensitivity assays: the MTT assay. Methods Mol. Biol. 731 (2011), 237–245.
35. Wang, H.C., Zhang, H.F., Guo, W.Y., Su, H., Zhang, K.R., Li, Q.X., et al. Hypoxic postconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: role of peroxynitrite formation. Apoptosis 11 (2006), 1453–1460.
36. Wang, M., Meng, X.B., Yu, Y.L., Sun, G.B., Xu, X.D., Zhang, X.P., et al. Elatoside C protects against hypoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes through the reduction of endoplasmic reticulum stress partially depending on STAT3 activation. Apoptosis 19 (2014), 1727–1735.
37. Yang, J.S., Hour, M.J., Kuo, S.C., Huang, L.J., Lee, M.R., Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38. Anticancer Res. 24 (2004), 1769–1778.